VERA
Vera Therapeutics Inc
29.80$
-1.9%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 0.0% | +138.9% | -5.3% | -7.2% | +77.9% | -6.9% | -5.2% | -10.5% | +42.0% | -15.4% | -14.3% | |
| – | +0.2% | +142.0% | -5.2% | -7.8% | +78.8% | -6.9% | -5.7% | -11.4% | +44.0% | -15.5% | -14.3% | |
| – | +66.5% | +51.3% | -63.7% | +8.7% | +239.9% | -40.5% | -10.8% | +17.6% | +514.0% | -67.8% | -57.3% | |
| – | +0.5% | +151.2% | -4.8% | -8.1% | +81.4% | -8.0% | -5.6% | -10.7% | +43.7% | -16.5% | -16.4% | |
| – | – | – | +20.2% | +1.9% | +88.9% | -5.0% | +17.2% | -20.1% | -2.1% | +19.0% | – | |
| – | +42.3% | -10.9% | +5.5% | +14.5% | -1.2% | -4.3% | +46.7% | +7.6% | +9.8% | -6.3% | +2.6% | |
| – | -9.4% | -34.8% | +26.6% | +43.7% | -4.1% | -13.7% | +53.3% | +24.8% | +27.6% | -15.5% | +7.0% | |
| – | -3.3% | -6.6% | -7.0% | -11.5% | -20.8% | -19.7% | -28.2% | -44.7% | +16.1% | – | – | |
| – | -9.6% | -53.1% | -10.5% | -1.3% | +66.6% | +20.8% | +42.1% | +36.4% | +22.0% | -36.5% | +4.8% | |
| – | +99.2% | +0.4% | +0.4% | +0.4% | +0.4% | +0.4% | +46.3% | +0.2% | +0.3% | +0.3% | +0.3% | |
| – | -17.8% | +247.7% | -7.3% | -11.8% | +99.7% | -7.3% | -12.5% | -14.8% | +51.6% | -17.3% | -18.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.2% | +14.7% | +7.4% | +0.3% | +0.0% | +16.0% | +0.2% | +0.1% | +0.6% | +11.3% | +0.5% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.